IDÀúÀå 
ùȭ¸éÀ¸·Î
°øÁö»çÇ×
°Ô½ÃÆÇ
ÄûÁîÄûÁî
ÁÖÀÓ±³¼ö Àλ縻
µ¿¹®È¸Àå Àλ縻
±³½Ç¿ª»ç
¿ª´ë ÁÖÀÓ±³¼ö
¿ª´ë µ¿¹®È¸Àå
±³½Ç¿ø ¼Ò°³
Àü°øÀÇ ¼Ò°³
ÀÚÁÖ ¿¬¶ôÇսôÙ
°ø½ÄÇà»ç
¿ì¸®´Â Çϳª
Ãß¾ïÀÇ ¾Ù¹ü
News Letter
¿¬º¸
¼ö¿ä Conference
¿©Àǵµ¼º¸ð
°­³²¼º¸ð
ÀÇÁ¤ºÎ¼º¸ð
¼ººó¼¾Æ®
¼º¸ðÀÚ¾Ö
¼º°¡
¼º¹Ù¿À·Î
´ëÀü¼º¸ð
°¡Å縯½ÉÆ÷Áö¿ò
µ¿¹®Çмú´ëȸ
º¸¹°Ã¢°í
µðīŬ·´
Á¤º¸¼öÁ¤
ÀÔÅð¿ø¼ö¼ú °ü¸®

 
ÀÛ¼ºÀÚ ºñ´¢±â°úÇб³½Ç µî·ÏÀÏ 2009-03-24 08:29:43
Á¶È¸ 623 ´Ù¿î 0
Á¦¸ñ   [°øÁö»çÇ×] 3¿ù 25ÀÏ ¼ö¿ä Ãʵ¶È¸
÷ºÎÆÄÀÏ    
³»¿ë
ÁÖÁ¦ : Prostate cancer

ÁÂÀå : ±è¼¼¿õ

¹ßÇ¥ :
R2 ÃÖ¸í¼± – Diet and Dietary Supplement Intervention Trials for the Prevention of Prostate Cancer Recurrence: A Review of the Randomized Controlled Trial Evidence, The Prognostic Impact of Seminal Vesicle Involvement Found at Prostatectomy and the Effects of Adjuvant Radiation: Data From Southwest Oncology Group 8794
   
R4 ÀÌÈ£Àç– The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free Survival, Neoadjuvant Platelet Derived Growth Factor Receptor Inhibitor Therapy Combined With Docetaxel and Androgen Ablation for High Risk Localized Prostate Cancer

½Ã°£: 2009³â 3¿ù 25ÀÏ (¼ö) ¿ÀÈÄ 6½Ã00ºÐ  

Àå¼Ò: ÁöÇÏ 1Ãþ 2ȸÀǽÇ

ÀÌÀü±Û   2009³â °¡Å縯ÀÇ´ë ºñ´¢±â°ú µ¿¹®ÃÑȸ
ÀÌÈÄ±Û   [°øÁö»çÇ×] 3¿ù 11ÀÏ ¼ö¿äÃʵ¶È¸

 
¸®Çôޱâ